Bharat Biotech Fact-Checks The Economic Times

Today's dynamic digital vaccine news typically involves fact-checking by trusted third parties, but it rarely includes a manufacturer openly responding to a potentially biased article.

Recently, the news industry has been challenged in its ability to comprehend vaccine-related clinical trials and technical journal articles.

For example, on June 16, 2024, The Economic Times published a headline stating, 'Bharat Bio's Rotavirus vaccine Rotavac may be unsafe for children: Study.'

Later that day, the company posted on X its response....Unfair Journalistic Practices and Breach of Ethics by The Economic Times.

While this vaccine efficacy debate may be illuminated on social media for days and probably never settled, vaccine hesitancy and reduced trust in the healthcare delivery system will continue.

In most countries, government agencies, such as the U.S. FDA, play vital roles in communicating virology (vaccines, immunotherapies, gene therapy, monoclonal antibodies) risks and benefits, not media-centric fiction.